Bill Ackman Goes Corporate Raider Route Backing Valeant in Allergan Bid

With Bill Ackman backing Valeant Pharmaceuticals $45 billion hostile takeover attempt for Botox maker Allergan, it appears as though activism has entered a new phase.
Author:
Publish date:

With Bill Ackman backing Valeant Pharmaceuticals $45 billion hostile takeover attempt for Botox maker Allergan, it appears as though activism has entered a new phase. But as seen with the Men's Wearhouse-Jos. A. Bank merger, it's just another way for dissident investors to push their agenda with corporations.